DHC

DHC is a healthcare REIT in the middle of a genuine operational turnaround that the GAAP net loss obscures. As a REIT, the headline -$286M loss is dominated by non-cash and one-time items — $262M of depreciation & amortization, $166M of asset impairments, and a $42.5M loss on debt extinguishment — not by a broken operating business. The cash engine, NOI, actually grew 7.6% to $278.5M, led by the SHOP (senior housing operating) segment, where NOI jumped 31.3% to $139.3M on comparable occupancy rising to 81.9% from 80.9% and average monthly rate climbing to $5,404 from $5,137. Management explicitly expects occupancy and rate strength to persist into 2026, and equity in earnings of investees swung positive (+$36.8M). Revenue has now risen three straight years to $1.54B, and the net loss is narrowing (+22.8% YoY).

The problem is the balance sheet and what sits between NOI and shareholders. Interest expense of $204.5M consumes roughly three-quarters of total NOI, and after $45.5M of G&A (itself up 71.6%), the business generated NEGATIVE operating cash flow of -$19.6M for the year — a red flag for any REIT, which exists to throw off distributable cash. The dividend has been gutted to $0.01 per share per quarter, and the 10-K warns it 'may remain at $0.01... for an indefinite period or be eliminated.' Long-term debt is $2.44B against just $105M of cash, with leverage at 1.62x liabilities/equity and an FY2023 current debt maturity of $700M flagged; the risk factors lead with refinancing risk, the cost of refinanced debt, possible credit-rating downgrades, and 'limited availability of debt capital to healthcare REITs generally.' DHC is funding its deleveraging by selling assets (a $117.7M gain on sale, total assets down 15.1%), which shrinks the earnings base even as it cuts debt.